her semaglutide cost Ozempic, Wegovy maker Novo Nordisk slams Hims & Hers Super Bowl ad for compounded GLP-1s Hims is in the crosshairs.

The news: Novo Nordisks GLP-1 drug semaglutide failed to slow the progression of Alzheimers disease in new study results, dimming hopes that GLP-1s might be approved to treat the condition

A separate review in PMC9915969 found that up to 49% of people taking tirzepatide experience some form of GI side effect (nausea, vomiting, or loose stools) this side effect is just one of the three

This kind of marketing might fall under what Timothy Caulfield calls scienceploitation

Individuals experiencing challenges with weight gain or difficulty losing weight

If you would prefer not to take a compounded medication, ask your prescriber to transition to the FDA-approved medication

Glutathione acts as the liver's "clean-up crew." It is heavily involved in Phase II detoxification, where it attaches to toxins to help them be excreted